Physician profile
Ronald L Rubenstein
NPI 1467568105
$9,072.45
in general payments reported to CMS, 2019-2025
11 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $142 · 2020: $33.50 · 2021: $20.95 · 2022: $16.76 · 2023: $8,732 · 2024: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $8,700 · Food and Beverage: $159.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $8,700.00 |
| Food and Beverage | $158.92 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Pharmaceuticals, INC. | $8,700.00 | 2023 | Eylea Hd |
| Intersect Ent, INC. | $79.13 | 2019 | |
| Stryker Corporation | $70.50 | 2019-2020 | |
| Smith+Nephew, INC. | $49.78 | 2023-2024 | Halo |
| Optinose US, INC. | $43.08 | 2024 | |
| Genzyme Corporation | $39.44 | 2022-2024 | |
| Regeneron Healthcare Solutions, INC. | $27.88 | 2024 | Dupixent |
| Cook Medical LLC | $20.95 | 2021 | |
| Glaxosmithkline, LLC. | $15.50 | 2024 | Nucala |
| Boston Scientific Corporation | $15.32 | 2019 | |
| Osiris Therapeutics INC. | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ronald Rubenstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.